Archives
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-07
-
T7 RNA Polymerase: Optimized RNA Synthesis for Research Work
2026-07-04
T7 RNA Polymerase, a recombinant enzyme expressed in E. coli, enables high-yield, sequence-specific in vitro transcription from linearized plasmid templates and PCR products. This article details streamlined protocols, advanced applications from RNA vaccine production to RNAi research, and expert troubleshooting tips to maximize experimental success.
-
Leucomycin (Kitasamycin): Resistance, MICs & Translational R
2026-07-03
Explore the advanced biological and resistance dynamics of Leucomycin (kitasamycin), a macrolide antibiotic, with a focus on clinically relevant MICs, resistance mechanisms, and translational inhibition in research. This article uniquely bridges molecular action with assay design and resistance profiling.
-
Flumequine: DNA Topoisomerase II Inhibitor for DNA Replicati
2026-07-03
Flumequine is a synthetic DNA topoisomerase II inhibitor with a verified IC50 of ~15 μM, enabling precise study of DNA replication and enzyme inhibition. Its high purity and solubility in DMSO make it a key tool for cancer and DNA damage research, as supported by peer-reviewed literature.
-
Intravesical p21 mRNA-LNP Therapy for Bladder Cancer: Insigh
2026-07-02
This study introduces a non-viral, localized strategy for bladder cancer using intravesical delivery of p21 mRNA-loaded lipid nanoparticles. The approach restores tumor suppressor function, suppresses tumor growth, and minimizes systemic toxicity, providing a new paradigm for targeted mRNA therapeutics in non-hepatic solid tumors.
-
Biotin-XX Tyramide Reagent: Precision Cell Surface Amplifica
2026-07-02
Biotin-XX Tyramide Reagent delivers membrane-impermeant, high-sensitivity amplification for cell surface protein detection—enabling researchers to distinguish extracellular targets even in complex tissues. Its robust performance in tyramide signal amplification workflows sets a new standard for immunohistochemistry and in situ hybridization applications.
-
Plant Cell Lysis Buffer for WB and IP: Advancing Native Prot
2026-07-01
Explore how Plant Cell Lysis Buffer for WB and IP enhances native protein extraction from plant samples. This cornerstone guide reveals advanced assay strategies, leveraging recent mechanistic insights into protein interactions for superior Western blotting and immunoprecipitation results.
-
ROS-Mediated Metabolic Reprogramming Halts CRC Progression
2026-07-01
Jiang et al. reveal that the natural compound CGF suppresses colorectal cancer (CRC) by inducing reactive oxygen species (ROS)-mediated metabolic disruption and mitochondrial dysfunction. Their integrative study links ABC transporter inhibition, ATP accumulation, and suppression of the MAPK/ERK/c-MYC axis to cell cycle arrest and apoptosis in CRC models.
-
Psora 4 as a Kv1.3 Blocker: Optimizing T Cell Research Proto
2026-06-30
Psora 4, a highly selective Kv1.3 blocker, unlocks precision immunomodulation by targeting effector memory T cells without broadly impairing naive or central memory populations. This article details advanced workflows, assay optimizations, and troubleshooting strategies—empowering researchers to harness Psora 4’s unique properties in autoimmune and kidney inflammation models.
-
Chlorin e6 Photosensitizer: Protocols, Innovations, and Trou
2026-06-30
Chlorin e6 (Ce6) redefines photodynamic therapy by bridging anticancer treatment and advanced antibacterial biomaterials. Explore workflow enhancements and troubleshooting tips to maximize ROS generation and assay reproducibility using APExBIO’s high-quality Ce6 photosensitizer.
-
Triple-Color Precision: Rethinking Molecular Standards in Tr
2026-06-29
This article delivers a strategic, mechanistic roadmap for translational researchers navigating the evolving landscape of protein analysis. By dissecting the impact of robust molecular weight standards—specifically the Prestained Protein Marker (Triple color, EDTA free, 10-250 kDa) from APExBIO—on the fidelity of SDS-PAGE and Western blot workflows, we synthesize recent mechanistic findings (e.g., ARID1A-PTEN-Akt axis in lung cancer resistance) with actionable guidance. The discussion bridges experimental rigor, competitive benchmarking, and translational impact, providing a blueprint for elevating protein research beyond standard paradigms.
-
Applied Workflows with the Live-Dead Cell Staining Kit K2081
2026-06-29
The Live-Dead Cell Staining Kit leverages Calcein-AM and Propidium Iodide dual staining for unmatched precision in live/dead cell discrimination across diverse research applications. Explore optimized protocols, troubleshooting expertise, and translational insight for advanced viability assays, especially in cytotoxicity and regenerative medicine studies.
-
Ionomycin Calcium Salt: Precision Calcium Ionophore for Canc
2026-06-28
Ionomycin calcium salt empowers researchers to precisely manipulate intracellular Ca2+ and decode pivotal signaling events in cancer, apoptosis, and protein secretion. This guide showcases advanced workflows, protocol refinements, and troubleshooting strategies for maximizing reliability and insight in functional assays using APExBIO’s trusted reagent.
-
Sabutoclax (SKU A4199): Reliable Pan-Bcl-2 Inhibition in Apo
2026-06-27
This article delivers a scenario-driven, evidence-based exploration of Sabutoclax (SKU A4199) for cell viability and apoptosis workflows in biomedical research. It addresses real laboratory challenges in assay reproducibility, selectivity, and compound reliability, demonstrating how Sabutoclax provides validated, quantifiable solutions for apoptosis induction and Bcl-2 family protein inhibition.
-
Technical Guide to HyperScribe™ T7 High Yield Cy3 RNA Labeli
2026-06-26
The HyperScribe™ T7 High Yield Cy3 RNA Labeling Kit Plus addresses the need for efficient generation of fluorescently labeled RNA probes for in situ hybridization and Northern blot applications. It is designed for sensitive fluorescent RNA detection workflows, and should not be used for diagnostic or clinical purposes.
-
A23187, Free Acid: Precision Calcium Ionophore for Functiona
2026-06-26
Explore how A23187, free acid, a benchmark calcium ionophore, enables advanced, quantitative dissection of cell fate decisions in vitro. This article uniquely bridges mechanistic insight with practical assay strategy, highlighting innovations in apoptosis and calcium signaling research.